Healthcare - Biotechnology - NASDAQ - US
$ 13.31
-7.05 %
$ 1.34 B
Market Cap
-13.72
P/E
BALANCE SHEET
376 M
ASSETS
29.5 M
LIABILITIES
347 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Day One Biopharmaceuticals, Inc.
| Current Assets | 375 M |
| Cash & Short-Term Investments | 366 M |
| Receivables | 0 |
| Other Current Assets | 8.93 M |
| Non-Current Assets | 774 K |
| Long-Term Investments | 0 |
| PP&E | 560 K |
| Other Non-Current Assets | 214 K |
| Current Liabilities | 29.5 M |
| Accounts Payable | 2.58 M |
| Short-Term Debt | 816 K |
| Other Current Liabilities | 26.1 M |
| Non-Current Liabilities | 0 |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| ASSETS | |||||
| Cash & Cash Equivalents | 230.8 | 85.3 | 284.3 | 43.7 | 27.3 |
| Short Term Investments | 135.6 | 257.0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 8.9 | 5.6 | 5.1 | 1.3 | 7 K |
| Total Current Assets | 375.3 | 347.9 | 289.4 | 45.1 | 27.3 |
| PP&E | 0.6 | 0.7 | 0.3 | 0.5 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.2 | 0.5 | 0.2 | 0.1 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 376.0 | 349.1 | 289.8 | 45.7 | 27.3 |
| LIABILITIES | |||||
| Accounts Payable | 2.6 | 0.3 | 1.7 | 0.2 | 69 K |
| Short Term Debt | 0.8 | 0.8 | 0.4 | 0.2 | 0 |
| Other Current Liabilities | 26.1 | 15.5 | 6.5 | 1.6 | 2.0 |
| Total Current Liabilities | 29.5 | 16.6 | 8.7 | 2.0 | 2.0 |
| Long Term Debt | 0 | 0.4 | 16 K | 0.2 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 0 | 92.0 | 30.5 |
| Total Liabilities | 29.5 | 17.0 | 8.7 | 94.2 | 32.5 |
| EQUITY | |||||
| Common Stock | 9 K | 7 K | 6 K | 2.0 | 2.0 |
| Retained Earnings | (458.6) | (269.7) | (127.5) | (56.8) | (12.8) |
| Other Accumulative Comprehensive Income/Loss | 9 K | 71 K | 0 | 637 | 111 |
| Total Equity | 346.5 | (269.7) | 162.3 | (48.5) | (5.2) |
| Total Liabilities and Equity | 376.0 | (252.6) | (118.8) | 45.7 | 27.3 |
| SHARES OUTSTANDING | |||||
| Common Shares Outstanding | 79.8 | 65.5 | 62.0 | 61.9 | 61.9 |